Dr. Rutkove is Professor of Neurology, Harvard Medical School and serves as Chief of the Division of Neuromuscular Disease in the Department of Neurology at Beth Israel Deaconess Medical Center. He received his medical degree from Columbia University’s College of Physicians and Surgeons, and his bachelor magna cum laude from Cornell University, College of Arts and Sciences.
Dr. Rutkove’s research focuses on the application of innovative techniques for the assessment of neuromuscular disease with an emphasis on electrical impedance and ultrasound methodologies. This work has been supported by numerous grants from the National Institutes of Health, NASA, and multiple foundations, and has resulted in well over 150 peer-reviewed publications. He is currently serving as an associate editor of neuromuscular disorders for Annals of Neurology. Dr. Rutkove is also a co-founder of Myolex, Inc, a San Francisco-based company commercializing muscle impedance tools for clinical care and consumer use. In 2011, he was awarded the Biomarker Challenge Prize from the non-profit foundation Prize4Life, Inc for his work demonstrating that electrical impedance measurements of muscle could speed clinical therapeutic studies in amyotrophic lateral sclerosis.